Really? Inquisitiveness? 100% of the inquisitive people wouldn't be any wiser with more data: they all require other people to interpret it for them. The company (and the FDA's former biostatistical expert) have already confirmed through their own analysis that all the endpoints were met. That is not enough though.
What would be enough? More analysis from the same people that apparently they (supposedly) don't trust? No, that would not be enough. What will be enough is initially the NDA filings (because they wouldn't file for approval if the FDA had not already told them they had the basis for doing so) and then the approvals. IMO, institutions will jump on the filings themselves and leave hedge funds jumping to reposition themselves. And we will see the erstwhile "skeptical" crowd disappear from this message board.
Anavex is in a perpetual state of "waiting" on data. The question is why. 5 months and counting. What is the holdup? Why make these grandiose claims and then hide the support?
News 
Market Data 
Discover 
